glp-1 review article A new by Clifford J. Rosen, MD, and Julie R. Ingelfinger, MD, describes a new generation of treatment with receptor agonists for persons with obesity with or without diabetes or GLP-1 Drugs Show Potential Anti-Cancer

Forty received oral semaglutide, 32 received injectable semaglutide, 12 received dulaglutide, while 8 received liraglutide (see Figure 2)

Sustainable results still depend mainly on healthy eating, regular physical activity, long-term lifestyle changes and following medical treatment, if needed

If a clinics complaint-resolution track record factors into your decision, this is worth weighing

The Downsides: Risks, Side Effects, and Concerns Despite the headline-making results, GLP-1 drugs are not without side effects or controversy

[DOI] [PMC free article] [PubMed] [Google Scholar] 177.Cassidy A., Mukamal K.J., Liu L., Franz M., Eliassen A.H., Rimm E.B

PMID: 73 KanwalF